Lynda Charters

Thurein Htoo, MS, MBA, CEO and co-founder of Qlaris Bio, took the podium at the New Horizons Forum at the Glaucoma 360 conference in San Francisco to discuss the performance of the company’s episcleral venous pressure eyedrop, QLS-111.

The Bascom Palmer program showcases neovascular, exudative, and degenerative eye diseases, and is designed for retina specialists, general ophthalmologists and researchers.

Specialists seek more information for use in the treatment of patients diagnosed with retinal diseases

Physicians explain how winter exacerbates symptoms of disease.

Minimally invasive, novel system achieves significant pressure level reductions.

Tailored approach can help physicians provide better outcomes for patients

Based on their findings, an international team of researchers is discouraging the application of atropine as a standard therapy for trabeculectomy surgery.

All events in the 2023 annual gathering, scheduled for February 2 to 4 in downtown San Francisco, California, will take place at a new venue, The Westin St Francis San Francisco on Union Square.

Coherus plans to file a Biologics License Application for FYB203 later in 2023 in preparation for an anticipated 2025 launch.

Study results show evidence for augmentation, offering hope to patients.

According to researchers, factors that were associated with all type of visual impairment included older age, lower education level, and lower income were associated with all types of visual impairment.

A study was conducted with the goal of evaluating a correlation between the number of peer-reviewed publications published before a residency and the subsequent peer-reviewed publications or career choices of doctors who graduated from an Ophthalmology residency program.

Continued education and financial incentives will become essential if biosimilars are to become a mainstay in ophthalmological markets, according to a recent report.

With the safety and efficacy of phacoemulsification having increased to the point that it is no longer standard practice to examine patients the day after surgery, clinicians may be unfamiliar with the potential causes of reduced vision when presented with a patient in the immediate postoperative period.

For ocular herpetic infection, topical antiviral medication alone is not sufficient. Investigators found that systemic antiherpetic treatment is needed to prevent recurrence and graft failure after PK.

The researchers conducted a retrospective chart review of patients with typical exudative AMD that had been treated with anti-VEGF therapy injections.

Investigators conducted a cohort study to determine if there is a correlation between intake of nitrate and AMD progression based on previous suggestions that low nitrate levels in the diet may put patients at risk of AMD progression.

The researchers reported that there was no significant difference in the AMD prevalence among the 3 study groups.

Survey participants were asked to enumerate the signs, symptoms, and complaints, the preoperative visual acuities; complications requiring removal or exchange; and secondary interventions.

Investigators test the efficacy of phentolamine alone and with low-dose pilocarpine.

According to one surgeon, the technique may reduce the need for biopsies.

Automated AI tool offers offline capability and hope for patients.

In this preliminary study, researchers found that renal function might affect the response to IVBI treatment in patients with DME.

Heavy silicone oil tamponade in secondary surgery for persistent full-thickness macular holes is a safe and efficient surgical method. Best-corrected visual acuity and minimum linear diameter before surgery may be indicators for anatomical success.

Survey of academic chairs and residency directors recognizes centers of excellence in Best Clinical Care, Best Residency, Best Research, and Best Overall Programs.

Spanish investigators found that local resection may offer better visual results and eye sparing without compromising local tumor control and survival.

The drug is expected to be available to eye care clinicians in the US during the second half of 2023.

The investigators explained that deficient ophthalmologic care is costly to patients, making the identification of groups not receiving adequate care of vital importance